We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

MINDRAY In-Vitro Diagnostics

As a global leader in in-vitro diagnostics, Mindray provides a wide range of efficient, reliable IVD solutions for la... read more Featured Products: More products

Download Mobile App





Mindray Medical Unveils Chemiluminescence Immunoassay System at AACC 2018

By Theresa Herman, Regional Director
Posted on 27 Mar 2019
Mindray Medical (Shenzhen, China), a leading provider of IVD devices and reagents with core business in hematology, clinical chemistry and CLIA, showcased one of the world's smallest, fully automated chemiluminescence immunoassay analyzers at AACC, the world’s largest exposition for clinical laboratory products and services. More...
This year’s annual event was held in Chicago, Illinois, USA, from July 31 to August 2.

Mindray’s solutions cover diverse laboratory needs worldwide. The company offers industry leading hematology analyzers and scalable automation lines, wide-range chemistry analyzers with traceable reagents, immunoassay systems with full assays, and products in flow cytometry, HPLC analysis, coagulation, etc.

At AACC, Mindray also unveiled the CL900i – a fully automated benchtop chemiluminescence immunoassay system with industry-leading small size that helps maximize laboratory space. With its industry-leading small footprint, fast throughput of 180 tests per hour and zero user maintenance, the CL900i benchtop analyzer provides easy and quality CLIA testing without taking up valuable laboratory floor space. The CL900i offers a broad range of testing results, 50 positions for reagents and 50 positions for samples, making it ideal for small laboratories looking for savings in cost as well as space and having high standards of quality.


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Integrated Biochemical & Immunological System
Biolumi CX8
New
Mini Vortex Mixer
Vornado
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.